Wichterman Troy bought BLFS
February 24, 2026 · Form 4 insider transaction
Wichterman Troy bought 31,150 shares of BioLife Solutions, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,150
Price
N/A
Total value
N/A
InsiderWichterman Troy
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after181,896
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.